ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AX02 | B | Thalidomide - 50mg | 11588 | 92622/1 | THALIDOMIDE BMS | 50mg | 28 | Capsule | Oral | Droguerie de l'Union | Celgene International | Switzerland | 27,387,764 L.L | 19.35 | D | Bristol-Myers Squibb Pharma EEIG | Ireland | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AX02 | B | Thalidomide - 50mg | 7404 | 186067/13 | THALIDOMIDE CELGENE | 50mg | 28 | Capsule | Oral | Droguerie de l'Union | Celgene International | Switzerland | 27,387,764 L.L | 19.35 | D | Celgen Europe Limited | UK | 2/5/2024 | 0 |